The prevalence of herbs use in conjunction with conventional medicines in Jamaica

Complementary Therapies in Medicine

Volumn 18, Issue 1, 2010, Pages 13-20

  Delgoda, Rupika ^a   Younger, Novie ^a   Barrett, Claudia ^b   Braithwaite, Jennifer ^b   Davis, Denise ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF TECHNOLOGY   (Jamaica)

Author keywords

Adverse drug reactions (ADRs); Caribbean; Herbal medicine; Pharmacokinetic; Polypharmacy

Indexed keywords

AMLODIPINE BESYLATE; AMOXICILLIN; BARALGIN; BECLOMETASONE DIPROPIONATE; CALCIUM OXIDE; CINNAMON EXTRACT; COMFREY EXTRACT; DANDELION EXTRACT; DICLOFENAC; DIPHENHYDRAMINE; ENALAPRIL; FLUTICASONE PROPIONATE; GARLIC EXTRACT; GUAVA EXTRACT; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; INSULIN; LANSOPRAZOLE; LOSARTAN POTASSIUM; METFORMIN; MOMORDICA CHARANTIA EXTRACT; NIFEDIPINE; PAROXETINE; RANITIDINE; RHYDOPHYULLUM TOMENTOSUM EXTRACT; ROSMARINUS OFFICINALIS EXTRACT; SALBUTAMOL; SATUREJA VIMINEA EXTRACT; THYMUS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DISEASE; CARDIOVASCULAR SYSTEM; CHILD; CHILD CARE; CITRUS FRUIT; CONTROLLED STUDY; CROTON LINEARIS; DANDELION; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASE; DRUG DESIGN; DRUG SURVEILLANCE PROGRAM; EAR DISEASE; ENDOCRINE DISEASE; EYE DISEASE; FEMALE; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SURVEY; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; INFANT; JAMAICA; KALANCHOE PINNATA; LIME (FRUIT); MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL PRACTICE; MEDICINAL PLANT; MEMORDICA CHARANTIA; MENTAL DISEASE; MUSCULOSKELETAL SYSTEM; NEUROLOGIC DISEASE; PATIENT CARE; PHARMACY; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; RESPIRATORY SYSTEM; RHYDOPHYULLUM TOMENTOSUM; SATUREJA VIMINEA; SCHOOL CHILD; SKIN DISEASE; STRUCTURED QUESTIONNAIRE; TREE OF LIFE; URBAN RURAL DIFFERENCE; UROGENITAL TRACT DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERB-DRUG INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; JAMAICA; MALE; MIDDLE AGED; PHARMACIES; PHYTOTHERAPY; PLANTS, MEDICINAL; POLYPHARMACY; PRESCRIPTION DRUGS; PREVALENCE; SELF MEDICATION; YOUNG ADULT;

EID: 76749111434     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.01.002     Document Type: Article

References (25)

1. Divakaran V., and Murugan A. Polypharmacy: an undervalued component of complexity in the care of elderly patients. European Journal of Internal Medicine 19 3 (2008) 225-226
2. Avorn J., and Shrank W. A substantial cuase of preventable illness. British Medical Journal (2008) 336956-336957
3. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalised patients: a Meta analysis of prospective studies. Journal of American Medical Association (1998) 2791200-2791205
4. Moore T., Cohen M., and Furberg C. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Archives of Internal Medicine 167 16 (2007) 1752-1759
5. Ruiz B., Garcia M., Aguirre U., and Aguirre C. Factors predicting hospital readmissions related to adverse drug reactions. European Journal of Clinical Pharmacology 64 7 (2008) 715-722
6. Brazier N., and Levine M. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. American Journal of Therapeutics (2003) 10163-10169
7. Delgoda R., and Westlake A.C. Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicology Review 23 4 (2004) 239-249
8. Barone G.W., Gurley B.J., Ketel B.L., Lightfoot M.L., and Abul-Ezz S.R. Drug interation between St. John's Wort and Cyclosporin. The Annals of Pharmacotherapy 34 9 (2000) 1013-1016
9. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32 6 (2002) 451-478
10. Robinson N., Blair M., Lorenc A., Gully N., Fox P., and Mitchell K. Complementary medicine use in multi-ethnic paediatric outpatients. Complementary Therapies in Clinical Practice (2008) 1417-1424
11. Meeks Gardner J., Grant D., Hutchinson S., and Wilks R. The use of herbal teas and remedies in Jamaica. West Indian Medical Journal 49 4 (2000) 331-335
12. Delgoda R., Ellington C., Barrett S., Gordon N., Clarke N., and Younger N. The practice of polypharmacy involving herbal and prescription medicines in the treatment of diabetes mellitus, hypertension and gastrointestinal disorders in Jamaica. West Indian Medical Journal 53 6 (2004) 400-405
13. Cochran W. Sampling techniques (1977), John Wiley & Sons, New York
14. Donner A., Birkett N., and Buck C. Randomisation by cluster: sample size requirement and analysis. American Journal of Epidemiology (1981) 114906-114914
15. Lohr S. Sampling: design and analysis (1999), Duxbury Press, New York
16. Adams G., Gulliford M., Ukoumunne O., Eldridge S., Chinn S., and Campbell M.J. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. Journal of Clinical Epidemiology (2004) 57785-57794
17. Lynch N., and Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescibed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complementary Therapies in Medicine (2007) 1584-1591
18. Eisenberg D. Unconventional medicine in the United States: prevalence, costs and the patterns of use. New England Journal of Medicine (1993) 328246-328252
19. Astin J.A. Why patients use alternative medicine. JAMA 279 19 (1998) 1548-1553
20. Clement Y., Williams A., Khan K., Bernard T., Bhola S., Fortune M., et al. A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complementary and Alternative Medicine (2005) 520-529
21. Clement Y. Herbal self-medication at primary health care facilities in Trinidad. The Journal of Alternative and Complementary Medicine 15 1 (2009) 6-7
22. Patki K., von Moltke L., and Greenblatt D. In vitro metabolism of midazolam, triazolam, nifedipine and testosterone by human liver microsomes and recombinant cytochromes P450: role of CYP3A4 and CYP3A5. Drug Metabolism and Disposition 31 7 (2003) 938-944
23. Foster B.C., Foster M.S., Vandenhoek S., Krantis A., Budzinski J.W., Arnason J.T., et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by Garlic. Journal of Pharmaceutical Science 4 2 (2001) 176-184
24. Shields M., Niazi U., Badal S., Yee T., Sutcliffe M., and Delgoda R. Inhibition of CYP1A1 by Quassinoids found in Picrasma excelsa. Planta Medica (2009) 75137-75141
25. Badal S., Shields M., Niazi U., Jacobs H., Sutcliffe M., and Delgoda R. Screening natural products for CYP1 inhibitors. Proceedings of the 17th international symposium on microsomes and drug oxidations (2008), Medimond Publishers, Saratoga Springs, New York, U.S.A. 20-24